Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I J Jacobs

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Histopathology|December 18, 2007
Grading of serous ovarian carcinoma: further evidence of a lack of agreement between conventional grading systemsN Singh, A Ayhan, U Menon, et al.
BMJ (Clinical Research Ed.)|November 30, 1996
Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort studyI J Jacobs, S Skates, A P Davies, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 26, 2000
Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinomaU Menon, S C Riley, J Thomas, et al.
Human Reproduction (Oxford, England)|January 1, 1990
Serum levels of CA 125 during the first trimester of normal outcome, ectopic and anembryonic pregnanciesI J Jacobs, T N Fay, J Yovich, et al.
Clinical Chemistry|May 1, 1999
OVX1 radioimmunoassay results are dependent on the method of sample collection and storageE V Hogdall, C K Hogdall, S K Kjaer, et al.
International Journal of Cancer|December 5, 2000
Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic massE V Hogdall, C K Høgdall, S Tingulstad, et al.
Clinical Radiology|February 16, 2005
The role of magnetic resonance imaging and ultrasound in patients with adnexal massesS A Sohaib, T D Mills, A Sahdev, et al.
Gynecologic Oncology|November 29, 2005
Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA?A G Rockall, S Ghosh, F Alexander-Sefre, et al.
Gynecologic Oncology|September 1, 2006
Somatic mitochondrial DNA mutations in primary and metastatic ovarian cancerP O Van Trappen, T Cullup, R Troke, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 14, 2004
Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based seriesN D Macdonald, H B Salvesen, A Ryan, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Histopathology|December 18, 2007
Grading of serous ovarian carcinoma: further evidence of a lack of agreement between conventional grading systemsN Singh, A Ayhan, U Menon, et al.
BMJ (Clinical Research Ed.)|November 30, 1996
Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort studyI J Jacobs, S Skates, A P Davies, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 26, 2000
Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinomaU Menon, S C Riley, J Thomas, et al.
Human Reproduction (Oxford, England)|January 1, 1990
Serum levels of CA 125 during the first trimester of normal outcome, ectopic and anembryonic pregnanciesI J Jacobs, T N Fay, J Yovich, et al.
Clinical Chemistry|May 1, 1999
OVX1 radioimmunoassay results are dependent on the method of sample collection and storageE V Hogdall, C K Hogdall, S K Kjaer, et al.
International Journal of Cancer|December 5, 2000
Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic massE V Hogdall, C K Høgdall, S Tingulstad, et al.
Clinical Radiology|February 16, 2005
The role of magnetic resonance imaging and ultrasound in patients with adnexal massesS A Sohaib, T D Mills, A Sahdev, et al.
Gynecologic Oncology|November 29, 2005
Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA?A G Rockall, S Ghosh, F Alexander-Sefre, et al.
Gynecologic Oncology|September 1, 2006
Somatic mitochondrial DNA mutations in primary and metastatic ovarian cancerP O Van Trappen, T Cullup, R Troke, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 14, 2004
Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based seriesN D Macdonald, H B Salvesen, A Ryan, et al.
Pageof 8